A randomized, phase 3, double-blind trial examining methotrexate and etanercept as monotherapy or in combinstion for treating psoriatic arthritis: A comparison of the composite measures used to evaluate disease activity

Podobne zapisy

• Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis
  od: Coates, L, i wsp.
  Wydane: (2020)
• Design and rationale of the Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA)
  od: Mease, P, i wsp.
  Wydane: (2018)
• Patient-reported outcomes data in patients with psoriatic arthritis from a randomised trial of etanercept and methotrexate as monotherapy or in combination
  od: Vibeke Strand, i wsp.
  Wydane: (2021-04-01)
• Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial
  od: Helliwell, PS, i wsp.
  Wydane: (2022)
• Methotrexate in psoriasis and psoriatic arthritis
  od: Coates, L, i wsp.
  Wydane: (2020)